Skip to main content
Premium Trial:

Request an Annual Quote

Enzo Biochem's Q1 Revenues Rise 2 Percent

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem today reported that its first-quarter 2011 revenues increased 2 percent as increased sales for its clinical labs business offset lower revenues for its life sciences unit.

The New York-based research products and testing firm brought in total revenues of $25.7 million for the three-month period ended Oct. 31, compared to revenues of $25.2 million for the first quarter of fiscal 2010.

Revenues for the Enzo Clinical Labs jumped 12 percent year over year to $12.4 million from $11.1 million, while product revenues, royalties, and license fees for Enzo Life Sciences declined 6 percent to $13.3 million from $14.1 million.

Enzo Biochem's net loss fell to $1.1 million, or $.03 per share, from $1.8 million, or $.05 per share, year over year.

The firm's R&D spending for Q1 was down 28 percent to $1.8 million, and its SG&A spending decreased 4 percent to $11 million.

Enzo finished the quarter with $31.6 million in cash, cash equivalents, and short-term investments.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.